Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-04-30T19:13:46.441Z Has data issue: false hasContentIssue false

Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX

Published online by Cambridge University Press:  15 May 2009

D. Barua
Affiliation:
Bacterial Diseases Unit, World Health Organization, Geneva
Y. Watanabe
Affiliation:
Bacterial Diseases Unit, World Health Organization, Geneva
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Yersinia enterocolitica serotype IX has been found to stimulate the production of vibriocidal antibody against Vibrio cholerae, particularly in Inaba serotype, in experimental rabbits and infected man to a significant degree. This activity could be absorbed by both Inaba and Yersinia antigens from anti-yersinia sera, but Yersinia antigen could not absorb vibriocidal activity from the anti-cholera sera, indicating a unilateral relation.

Vibrio agglutinating antibody, particularly against Ogawa, in anti-yersinia rabbit or human sera was found to be less liable to non-specific stimulation.

V. cholerae, while removing vibriocidal antibody, could not absorb the Yersinia agglutinin from anti-yersinia sera, suggesting that there is a different determinant for these two types of antibody activities.

The non-specific production of vibriocidal antibody by Y. enterocolitica type IX indicates the need for caution in the interpretation of the results of vibriocidal tests where such organisms are prevalent.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1972

References

REFERENCES

Ahvonen, P. & Sievers, K. (1969). Yersinia enterocolitica infection associated with Brucella agglutinins. Acta medica Scandinavica 185, 121–5.CrossRefGoogle ScholarPubMed
Ahvonen, P., Jansson, E. & Aho, K. (1969). Marked cross-agglutination between Brucellae and a subtype of Yersinia enterocolitica. Acta pathologica et microbiologica Scandinavica 75, 291–5.Google Scholar
Carlsson, M. G., Ryd, H. & Sternby, N. H. (1964). A case of human infection with Pasteurella pseudotuberculosis X. Acta pathologica et microbiologica Scandinavica 62, 128–32.CrossRefGoogle ScholarPubMed
Corbel, M. J. & Cullen, G. A. (1970). Differentiation of the serological response to Yersinia enterocolitica and Brucella abortus in cattle. Journal of Hygiene 68, 519–30.Google ScholarPubMed
Davidsohn, I. & Walker, P. H. (1935). Nature of heterophilic antibodies in infectious mononucleosis. American Journal of Clinical Pathology 5, 455–65.CrossRefGoogle Scholar
Eisele, C. W., McCullough, N. B., Beal, G. A. & Burrows, W. (1946). Development of Brucella agglutinins in humans following vaccination for cholera. Proceedings of the Society for Experimental Biology and Medicine 61, 8991.CrossRefGoogle ScholarPubMed
Ewing, W. H. (1953). Serological relationships between Shigella and coliform cultures. Journal of Bacteriology 66, 333–40.CrossRefGoogle ScholarPubMed
Feeley, J. C. (1969). Somatic O antigen relationship of Brucella and Vibrio cholerae. Journal of Bacteriology 99, 645–9.CrossRefGoogle ScholarPubMed
Finkelstein, R. A., Powell, C. J. Jr, Woodrow, J. C. & Krevans, J. R. (1965). Serological responses in man to a single small dose of cholera vaccine with special reference to the lack of influence of ABO blood group on natural antibody or immunological responsiveness. Bulletin of the Johns Hopkins Hospital 116, 152–60.Google ScholarPubMed
Frederiksen, W. (1964). A study of some Yersinia pseudotuberculosis-like bacteria (‘Bacterium enterocoliticum’ and ‘Pasteurella X’). In: Proceedings of the XIV Scandinavian Congress of Pathology and Microbiology, pp. 103–4. Oslo University Press.Google Scholar
Gallut, J. (1950). Relations antigéniques entre vibrion cholérique et Brucelles. Annales de l' Institut Pasteur 79, 335–8.Google Scholar
Gangarosa, E. J., DeWitt, W. E., Feeley, J. C. & Adams, M. R. (1970). Significance of vibriocidal antibodies with regard to immunity to cholera. Journal of Infectious Diseases 121 (suppl.), S36–S43.CrossRefGoogle ScholarPubMed
Knapp, W. & Thal, E. (1963). Untersuchungen über die kulturell-biochemischen, serologischen, tierexperimentellen und immunologischen Eigenschaften einer vorläufig ‘Pasteurella X’ benannten Bacterienart. Zentralblatt für Bakteriologie, Parasitenkunde, Infektions-krankheiten und Hygiene. I. Abt. Medizinish-hygienische Virusforschung und Parasitologie. Originale, 190, 472–84.Google Scholar
Makulu, A., Gatti, F., Mollaret, H. H. & Vandepitte, J. (1969). Sur l'existence d'infections humaines à Yersinia enterocolitica en République démocratique du Congo. Bulletin de la Société de pathologic exotique et de ses filiales 62, 452–60.Google Scholar
Mathur, T. N. (1960). The development of Brucella agglutinins in cholera inoculated persons. Indian Journal of Medical Research 48, 309–14.Google Scholar
Niléhn, B. (1967). Studies on Yersinia enterocolitica. Characterization of 28 strains from human an animal sources. Acta pathologica et microbiologica Scandinavica 69, 8391.CrossRefGoogle Scholar
Verwey, W F., Watanabe, Y., Guckian, J. C., Williams, H. R. Jr, Phillips, P. E., Rocha, S. S. Jr & Bridgeforth, E. B. (1969). Serological responses of human volunteers to cholera vaccine. Texas Reports on Biology and Medicine 27, Suppl. 1, 243–74.Google Scholar
Winblad, S. (1967). Studies on serological typing of Yersinia enterocolitica. The XV Scandinavian Congress of Pathology & Microbiology. Acta pathologica et microbiologica Scandinavica, Supplementum 187, 115.Google Scholar
Winblad, S., Niléhn, B. & Sternby, N. H. (1966). Yersinia enterocolitica (Pasteurella X) in human enteric infections. British Medical Journal ii, 1363–6.CrossRefGoogle Scholar